Matches in Wikidata for { <http://www.wikidata.org/entity/Q65316722> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q65316722 description "clinical trial" @default.
- Q65316722 description "ensayu clínicu" @default.
- Q65316722 description "klinisch onderzoek" @default.
- Q65316722 description "клінічне випробування" @default.
- Q65316722 name "Double-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin (MK-0431J-842)" @default.
- Q65316722 name "Double-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin" @default.
- Q65316722 type Item @default.
- Q65316722 label "Double-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin (MK-0431J-842)" @default.
- Q65316722 label "Double-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin" @default.
- Q65316722 prefLabel "Double-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin (MK-0431J-842)" @default.
- Q65316722 prefLabel "Double-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin" @default.
- Q65316722 P1050 Q65316722-6DBF29DB-A2A3-4264-86BD-100F93E74918 @default.
- Q65316722 P1132 Q65316722-AB2FE763-62A0-43A8-8197-A7DE0ECFD387 @default.
- Q65316722 P1476 Q65316722-A93614C0-A683-49BD-942A-686C3E249A49 @default.
- Q65316722 P2899 Q65316722-4C46D4BA-6F06-4780-8620-3054A6758370 @default.
- Q65316722 P3098 Q65316722-F7B839C8-3837-45EA-A86F-2D27F5748948 @default.
- Q65316722 P31 Q65316722-0BEA07F9-901A-40CC-A833-67E44C774EDB @default.
- Q65316722 P4844 Q65316722-65B67019-AC3A-4C2C-B100-107C5D4C6213 @default.
- Q65316722 P580 Q65316722-4719A933-0F45-49E6-953A-5DE99943A503 @default.
- Q65316722 P582 Q65316722-18DA8529-C672-4D64-B4F6-56015A0C3B41 @default.
- Q65316722 P6099 Q65316722-4200D17D-DE76-477C-9C5F-99B97B1988A4 @default.
- Q65316722 P8363 Q65316722-ED986572-E35A-4096-BBC7-3EE9071CF191 @default.
- Q65316722 P1050 Q12206 @default.
- Q65316722 P1132 "+141" @default.
- Q65316722 P1476 "A Phase III, Multicenter, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Trial to Assess the Safety and Efficacy of Addition of Sitagliptin in Japanese Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin Monotherapy in Addition to Diet and Exercise Therapy" @default.
- Q65316722 P2899 "+20" @default.
- Q65316722 P3098 "NCT02577016" @default.
- Q65316722 P31 Q30612 @default.
- Q65316722 P4844 Q17193526 @default.
- Q65316722 P580 "2015-11-05T00:00:00Z" @default.
- Q65316722 P582 "2016-11-18T00:00:00Z" @default.
- Q65316722 P6099 Q42824827 @default.
- Q65316722 P8363 Q78089383 @default.